Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $0.74 USD
Change Today -0.0212 / -2.77%
Volume 418.1K
RNN On Other Exchanges
As of 8:04 PM 04/17/15 All times are local (Market data is delayed by at least 15 minutes).

Key Executives - rexahn pharmaceuticals inc (RNN)

NameBoard RelationshipsTitleAge
Peter D. Suzdak Ph.D.10 RelationshipsChief Executive Officer and Director55
Rakesh Soni No RelationshipsPresident and Chief Operating Officer58
Chang H. Ahn Ph.D.15 RelationshipsFounder, Chairman of the Board and Chief Scientist62
Tae Heum Jeong D. Mgt.No RelationshipsChief Financial Officer, Senior Vice President and Secretary43
Ely Benaim M.D.No RelationshipsChief Medical Officer53

Board Members - rexahn pharmaceuticals inc (RNN)

NameBoard RelationshipsPrimary CompanyAge
Chang H. Ahn Ph.D.15 RelationshipsRexahn Pharmaceuticals, Inc.62
Peter D. Suzdak Ph.D.10 RelationshipsRexahn Pharmaceuticals, Inc.55
Charles Beever 10 RelationshipsRexahn Pharmaceuticals, Inc.61
Kwang Soo Cheong 10 RelationshipsRexahn Pharmaceuticals, Inc.53
Michael E. Thase M.D.42, Inc.--

Executive Committees* - rexahn pharmaceuticals inc (RNN)

Committee NameChairpersonBoard RelationshipsMembers
Audit CommitteeKwang Soo Cheong 10 Relationships3 Executives
Compensation CommitteeCharles Beever 10 Relationships3 Executives
Nominating CommitteePeter C. Brandt 33 Relationships3 Executives
Corporate Governance CommitteePeter C. Brandt 33 Relationships3 Executives
Advisory BoardMichael E. Thase M.D. 42 Relationships2 Executives
View RNN Committee Details
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RNN:US $0.74 USD -0.0212

RNN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for RNN.
View Industry Companies

Industry Analysis


Industry Average

Valuation RNN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales -- Not Meaningful
Price/Book 5.0x
Price/Cash Flow NM Not Meaningful
TEV/Sales -- Not Meaningful

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REXAHN PHARMACEUTICALS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at